| 名稱 | AXL （Gas6 Dependent）/BaF3 |
| 型號 | CBP73249 |
| 報價 |  |
| 特點 | AXL （Gas6 Dependent）/BaF3，母細胞：BaF3，AXL （TYRO7） 是一種受體酪氨酸激酶，在各種形式的癌癥中過度表達，包括乳腺癌、前列腺癌、結(jié)腸直腸癌和非小細胞癌。 AXL 過表達已被證明可促進腫瘤進展和轉(zhuǎn)移并降低抗腫瘤免疫反應(yīng)，使 AXL 成為抗癌治療的有吸引力的候選者。 |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73249AXL （Gas6 Dependent）/BaF3
- 詳細內(nèi)容
| CBP73249 | |
| I. Introduction | |
Cell Line Name： | AXL (Gas6 Dependent)/BaF3 |
Host Cell: | BA/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10% FBS+2 ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
| AXL (TYRO7) is a receptor tyrosine kinase that is overexpressed in various forms of cancer, including breast, prostate, colorectal, and non-small cell cancers. AXL overexpression has been shown to encourage tumor progression and metastasis and to decrease the anti-tumor immune response, making AXL an attractive candidate for anticancer therapies. | |
| III. Representative Data | |
1. Anti-proliferation assay | |
| |
Figure 1. Anti-proliferation assay of three reference compounds on the AXL (Gas6 Dependent)/BaF3 Stable Cell Line. | |
